dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Ravimiamet
Väljaminev kiriAvalik

Answers to Inquiry

Ravimiamet · 29. juuli 2024
Viit
RST-1/2739-2
Registreeritud
29. juuli 2024
Dokumendi liik
Väljaminev kiri
Adressaat
DatamedIQ GmbH
Saabumis/saatmisviis
Outlook
Funktsioon
RST Ravimistatistika tegemine
Sari
RST-1 Ravimistatistika alane kirjavahetus
Toimik
RST-1/2024
Vastutaja
Marju Sammul (RA, Ravimiohutuse osakond, Statistikabüroo)

Failid

  • 📎E-kiri - 2024-07-29T145303.274.eml62 KB

Sisu (failidest)

Saatja: "Marju Sammul" <[email protected]> Saaja: "Dominique Ziegelmayer" <[email protected]> Teema: RE: Information about the Estonian ePharmacy-Market Kuupäev: 2024-03-11 07:32 Dear Dominique, Please find the information about e-Pharmacy-market in Estonia (the turnover in million euros) below: Estonian Pharmacy-market 2021 2022 2023 Turnover of general pharmacies 461 506 542 Turnover of other products 138 147 149 Turnover of medicines 323 359 393 Turnover of non-prescription medicines 63 75 75 Turnover of prescription medicines 259 283 317 Estonian e-Pharmacy-market 2021 2022 2023 Turnover of e-pharmacies 8.7 10.3 12.6 Turnover of other products 6.8 7.6 9.6 Turnover of medicines 1.9 2.7 3.0 Turnover of non-prescription medicines 0.8 1.1 1.0 Turnover of prescription medicines 1.1 1.6 2.0 Share of e-Pharmacies 2021 2022 2023 Turnover of pharmacies 1,9% 2,0% 2,3% Turnover of other products 5,0% 5,2% 6,4% Turnover of medicines 0,6% 0,8% 0,8% Turnover of non-prescription medicines 1,2% 1,4% 1,4% Turnover of prescription medicines 0,4% 0,6% 0,6% Best regards, Marju Sammul Bureau of Statistics Department of Post-authorisation Safety State Agency of Medicines Estonia <mailto:[email protected]> [email protected] 1 Nooruse Street 50411 Tartu <https://urldefense.com/v3/__http:/www.ravimiamet.ee__;!!NI2rKV_i!8suDN_Yjt5gKw0x9UWtY2CSpVfy_5OCSyLSF6WgMAcCD8H7slV7D3wMjvN2SyY_4mF_etwqs2f3Wcm5442BRgPmWw-pMs40-$> www.ravimiamet.ee This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have received. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal. From: Dominique Ziegelmayer < <mailto:[email protected]> [email protected]> Sent: neljapäev, 7. märts 2024 13:56 To: Ravimiamet < <mailto:[email protected]> [email protected]> Subject: Information about the Estonian ePharmacy-Market Dear Sirs and Maddams, We are trying to compile a report on the different pharmaceutical markets in the EU. Can you give us information about the online-market share (rx and nonRx if possible) and the growth of the online Pharmacy-market in Estonia? Mit freundlichen Grüßen / Best Regards Dominique Ziegelmayer <https://datamediq.com/> Dr. Dominique Ziegelmayer Chief Executive Officer (CEO) T : +49 221 999 895 20 Im Mediapark 4b, 50670 Köln datamediq.com 🍸 Save The Date: Insights On The Rocks - 12.06.2024 <https://meetings-eu1.hubspot.com/dominique-ziegelmayer> <https://data.sigilium.com/signatures/rcxcojvf6uq6awshivhdhrvmr0534rc/link> <https://www.linkedin.com/company/datamediq/> <https://www.instagram.com/datamediq/> <https://data.sigilium.com/signatures/rcxcojvf6uq6awshivhdhrvmr0534rc/redirect_link> DatamedIQ GmbH | Sitz: Köln, Amtsgericht Köln HRB 96213 Geschäftsführer: Dr. Dominique Ziegelmayer
Allikas: Ravimiamet dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel